MELBOURNE, Australia and PRINCETON, N.J., April 03, 2024 (GLOBE NEWSWIRE) — Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage […]
Carlsbad, CA, April 03, 2024 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company […]
Committed to Advancing Donlin Gold to Full Feasibility Study Extensive Engagement Reinforcing and Deepening Donlin Gold’s Social License Strong Treasury […]